Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice

@STL_Biotech Would love to see what you've got! Last I had searched was quite a while ago but this was the highest ORR of any respectable size I could find (16% in arm A): https://t.co/kvMmAJtqWY Don't think CRDF used to cite this in their pres but I th

@MBbiotech @sentivcapital No. There's a paper saying in real life, FOLFIRI and Avastin combo for KRAS gives around 20% ORR, not the 5% on company's slides. --> arm A, 5 PR (Partial Response), 15 SD (Stable Disease), 8 PD (Progressive Disease), https://